[HTML][HTML] Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the …
R Wender, DR Matthews - Diabetologia, 2012 - Springer
Glycaemic management in type 2 diabetes mellitus has become increasingly complex and,
to some extent, controversial, with a widening array of pharmacological agents now …
to some extent, controversial, with a widening array of pharmacological agents now …
[引用][C] Erratum to: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) …
SE Inzucchi, RM Bergenstal, JB Buse, M Diamant… - Diabetologia, 2013 - infona.pl
Erratum to: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach.
Position statement of the American Diabetes Association (ADA) and the European Association …
Position statement of the American Diabetes Association (ADA) and the European Association …
[PDF][PDF] Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the …
SE Inzucchi, RM Bergenstal, JB Buse, M Diamant… - 2012 - uedrs.org
Glycaemic management in type 2 diabetes mellitus has become increasingly complex and,
to some extent, controversial, with a widening array of pharmacological agents now …
to some extent, controversial, with a widening array of pharmacological agents now …
[引用][C] Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the …
SE Inzucchi, RM Bergenstal, JB Buse, M Diamant… - Diabetologia, 2012 - europepmc.org
Intensive glycemic control and the prevention of cardiovascular events: implications of the
ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes …
ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes …
[PDF][PDF] Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the …
SE Inzucchi, RM Bergenstal, JB Buse, M Diamant… - 2012 - uedrs.org
Glycaemic management in type 2 diabetes mellitus has become increasingly complex and,
to some extent, controversial, with a widening array of pharmacological agents now …
to some extent, controversial, with a widening array of pharmacological agents now …
[PDF][PDF] Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the …
SE Inzucchi, RM Bergenstal, JB Buse, M Diamant… - 2012 - glucomen.co.uk
Glycaemic management in type 2 diabetes mellitus has become increasingly complex and,
to some extent, controversial, with a widening array of pharmacological agents now …
to some extent, controversial, with a widening array of pharmacological agents now …
Erratum to: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the …
SE Inzucchi, RM Bergenstal, JB Buse, M Diamant… - Diabetologia, 2013 - researchgate.net
In the text box 'Properties of currently available glucoselowering agents that may guide
treatment choice in individual patients with type 2 diabetes mellitus' vildagliptin was …
treatment choice in individual patients with type 2 diabetes mellitus' vildagliptin was …
[PDF][PDF] Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the …
SE Inzucchi, RM Bergenstal, JB Buse… - 2012 - cardiologia.publicacionmedica.com
Glycaemic management in type 2 diabetes mellitus has become increasingly complex and,
to some extent, controversial, with a widening array of pharmacological agents now …
to some extent, controversial, with a widening array of pharmacological agents now …
[PDF][PDF] Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the …
SE Inzucchi, RM Bergenstal, JB Buse, M Diamant… - 2012 - dagensdiabetes.se
Glycaemic management in type 2 diabetes mellitus has become increasingly complex and,
to some extent, controversial, with a widening array of pharmacological agents now …
to some extent, controversial, with a widening array of pharmacological agents now …
[引用][C] Erratum to: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) …
SE Inzucchi, RM Bergenstal, JB Buse, M Diamant… - Diabetologia, 2013 - Springer
In the text box 'Properties of currently available glucoselowering agents that may guide
treatment choice in individual patients with type 2 diabetes mellitus' vildagliptin was …
treatment choice in individual patients with type 2 diabetes mellitus' vildagliptin was …
